Prognostic Role of PD-L1 and IDO-1 Expression in Sinonasal Carcinoma
ORL · 2025
DOI: 10.1159/000546118 ↗Kurz gefasst
Fachartikel in der Zeitschrift ORL, 2025. Verfasst von Daria Rometsch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, B7-H1 Antigen, Paranasal Sinus Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Introduction
Sinonasal carcinomas (SNC) are rare, aggressive tumours with complex immunological aspects. Still, prognostic markers are missing. The study aimed to investigate the relationship between immune checkpoints – specifically programmed death-ligand 1 (PD-L1) and Indolamin-2,3-dioxygenase 1 (IDO-1) – and clinical parameters in SNC.
Methods
In this monocentric study immunohistochemical analysis of the checkpoints PD-L1 and IDO-1 was carried out retrospectively in 85 SNC patients from 2004 to 2018. Tumour proportion score (TPS), combined positive score (CPS) and combined IDO-1 score classified the PD-L1 and IDO-1 expression. The study was conducted in a specialized tertiary care centre, indicating comprehensive multidisciplinary care with surgical, radiotherapeutic, and systemic treatment intervention.
Results
Over a median observation period of 41 months, 52 squamous cell carcinomas (SCC, 61%) and 33 adenocarcinomas (AC, 39%) were included. A total of 31 patients (37%) were classified in UICC IV, 89.4% (n = 76) received a primary resection. Three-year progression-free survival (PFS)/overall survival (OS) rates were 63.6%/81.4% in SCC and 73.1%/82.5% in AC, respectively. Sinonasal AC showed significantly more frequently negative PD-L1 expression and CPS 50%, combined low IDO-1 score and high UICC stage showed significantly worse 3-year PFS and OS values (p < 0.05).
Conclusion
The study identifies PD-L1 and IDO-1 as possible prognostic factors for sinonasal SCC, but less so for sinonasal AC. A TPS score >50% and combined low IDO-1 score correlate with shortened 3-year PFS and OS in sinonasal SCC. Immune checkpoints could, therefore, represent important target molecules for the prognosis assessment of sinonasal SCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Münster, Münster, Germany.
Zitieren
APA
Rometsch, D., Simon, F., Göttker, P., Heitkötter, F. S., Riders, A., Rudack, C., & Oberste, M. (2025). Prognostic Role of PD-L1 and IDO-1 Expression in Sinonasal Carcinoma. ORL. https://doi.org/10.1159/000546118
Vancouver
Rometsch D, Simon F, Göttker P, Heitkötter FS, Riders A, Rudack C, et al. Prognostic Role of PD-L1 and IDO-1 Expression in Sinonasal Carcinoma. ORL. 2025. doi:10.1159/000546118
BibTeX
@article{Rometsch2025,
author = {Rometsch, Daria and Simon, Frank and Göttker, Philipp and Heitkötter, Felix Simon and Riders, Armands and Rudack, Claudia and Oberste, Maximilian},
title = {Prognostic Role of PD-L1 and IDO-1 Expression in Sinonasal Carcinoma},
journal = {ORL},
year = {2025},
doi = {10.1159/000546118}
}
EUVIMED